Treatment
TS-172 clinical trials
We’re tracking 5 recruiting studies that include TS-172, each written for real people, not researchers, below.
Recruiting studies
- NCT07548840RecruitingPhase 3
Testing TS-172 to lower phosphorus in dialysis patients
This study tests a new medication called TS-172 for people on dialysis whose phosphorus levels stay high despite taking other phosphorus-lowering drugs. The goal is to see if TS-172 can better control phosphorus and help prevent bone and heart problems that high phosphorus causes.
TokyoAges 18 years+ - NCT07285304RecruitingPhase 3
Long-term study of TS-172 for high phosphorus on dialysis
This trial tests a new medicine, TS-172, to lower high phosphorus levels in people with kidney disease who are on hemodialysis. It looks at safety and effectiveness over a longer period.
TokyoAges 18 years+ - NCT07548853RecruitingPhase 3
Testing TS-172 to Lower Phosphorus in Peritoneal Dialysis Patients
This study tests whether a new medicine called TS-172 can help lower phosphorus levels in patients on peritoneal dialysis (a type of kidney treatment). High phosphorus can cause bone problems and other complications, so the trial aims to see if this drug works better than current treatments.
TokyoAges 18 years+ - NCT07285291RecruitingPhase 3
Study of a new drug for high phosphorus in dialysis patients
This trial tests a new medicine called TS-172 for people with high phosphorus levels who are on hemodialysis. It aims to lower phosphorus levels and is taken along with your current phosphate binder medication.
TokyoAges 18 years+ - NCT07231029RecruitingPhase 1
Study of TS-172 in people with reduced liver function
This study tests how an experimental drug (TS-172) is processed in the body by comparing people with mild to moderate liver disease to those with normal liver function. It may help doctors understand how to dose the drug safely for people with liver problems.
TokyoAges 18–75
What TS-172 is being studied for
Conditions with recruiting TS-172 studies.
Common questions
- Are there clinical trials studying TS-172?
- Yes. Clin2 currently lists 5 recruiting studies that include TS-172, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a TS-172 trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is TS-172 an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether TS-172 or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.